• LAST PRICE
    0.4470
  • TODAY'S CHANGE (%)
    Trending Down-0.0065 (-1.4333%)
  • Bid / Lots
    0.4500/ 2
  • Ask / Lots
    0.4600/ 19
  • Open / Previous Close
    0.4500 / 0.4535
  • Day Range
    Low 0.4300
    High 0.4980
  • 52 Week Range
    Low 0.4216
    High 3.8700
  • Volume
    99,019
    below average

Search Criteria

Filter search criteria using below inputs

Click on magnifying glass icon to search

Search Criteria - - - Stocks (0)
CompanyCountrySymbol
Select an index
Price Comparison Graph. See accessible table below
1 Day Comparison Chart Accessibility Table. Thursday's close: 0.45395
TimeVolumeASLN
09:32 ET11660.45
09:36 ET3000.4581
09:48 ET25000.458
10:03 ET107680.45
10:15 ET13500.4501
10:17 ET3500.4503
10:21 ET1000.4503
10:37 ET284880.4301
10:39 ET1000.4301
10:48 ET1000.4579
10:50 ET2000.45
10:51 ET13980.44
10:53 ET4000.4412
11:00 ET3120.44
11:18 ET44850.4303
11:20 ET4000.4303
11:22 ET1000.4303
11:42 ET2300.44
11:44 ET1100.458
11:51 ET3000.449
12:03 ET3000.456
12:18 ET5000.44
12:23 ET249880.456
12:25 ET5000.455999
12:36 ET11000.44
12:38 ET5000.4539
12:39 ET1000.44
12:50 ET1000.44
12:54 ET9000.447
12:56 ET1000.44
01:03 ET1000.44
01:06 ET20000.4428
01:08 ET5000.44
01:12 ET1000.44
01:26 ET1500.4411
01:33 ET7000.44
01:42 ET1000.44
02:02 ET2000.44
02:33 ET1000.44
02:36 ET1000.44
02:40 ET1000.44
02:44 ET6000.447
02:45 ET1000.44
03:14 ET19930.445
03:16 ET4000.448
03:18 ET8000.44
03:20 ET1000.445
03:21 ET18000.44
03:23 ET1000.44
03:25 ET14000.4519
03:27 ET2000.44
03:30 ET1000.44
03:32 ET1000.44
03:36 ET1000.44
03:39 ET1000.44
03:56 ET6210.4474
03:57 ET6990.44
03:59 ET1720.447
Data delayed at least 15 minutes.
Industry Peers Overview Table
Company sortableMarket Cap sortableP/E Ratio (TTM) sortableEPS Growth (5yr) sortable
United StatesASLN
Aslan Pharmaceuticals Ltd
31.2M
-1.0x
---
United StatesSPRB
Spruce Biosciences Inc
31.7M
-0.7x
---
United StatesONCS
OncoSec Medical Inc
30.3M
-0.7x
---
United StatesONCR
Oncorus Inc
32.1M
-0.5x
---
United StatesBIXT
Bioxytran Inc
32.2M
-7.5x
---
United StatesNBSE
NeuBase Therapeutics Inc
32.3M
-1.0x
---
As of 2022-05-22

Company Information

ASLAN Pharmaceuticals Limited (ASLAN) is a clinical-stage immunology focused biopharmaceutical company. The Company is engaged in developing treatments to transform the lives of patients. The Company is focused developing ASLAN004, an antibody targeting the IL-13 receptor, in atopic dermatitis, and ASLAN003, an oral inhibitor of dihydroorotate dehydrogenase (DHODH), which is being developed for autoimmune disease. ASLAN has a team in Menlo Park, California, and in Singapore, and conducts clinical development programs globally.

Contact Information

Headquarters
83 Clemenceau Avenue, #12-03 Ue Square, Singapore 239920
Phone
---
Fax
---

Executives

Independent Chairman of the Board
Andrew Howden
Chief Executive Officer, Director
Carl Firth
Chief Operating Officer, Head of Finance
Kiran Asarpota
General Counsel
Ben Goodger
Chief Business Officer
Stephen Doyle

Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.

Open a New Account, or Login if you're a client.

You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.

Open a New Account, or Login if you're a client.

Fundamentals Table
Market Cap
$31.2M
Revenue (TTM)
$0.00
Shares Outstanding
13.9M
Dividend Yield
0.00%
Annual Dividend Rate
---
Ex-Dividend Date
01-01-01
Pay Date
01-01-01
Beta
2.41
EPS
$-0.44
Book Value
$-0.25
P/E Ratio
-1.0x
Price/Sales (TTM)
---
Price/Cash Flow (TTM)
---
Operating Margin
---
*GAAP = prior to non-GAAP analyst adjusted earnings.

Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.

Open a New Account, or Login if you're a client.